Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB
Clinical trial NCT02354014 · RECRUITING
Trial details
- NCT number
- NCT02354014
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2027-02-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.